-+ 0.00%
-+ 0.00%
-+ 0.00%

Eupraxia Pharmaceuticals Q2 EPS $(0.23), Inline

Benzinga·08/11/2026 21:32:27
Listen to the news
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 11.54 percent increase over losses of $(0.26) per share from the same period last year.